Openbaar Beoordelingsrapport - Samenvatting Generieke geneesmiddelen Aprepitant Teva 80 mg, 125 mg, en 125 mg + 80 mg, harde cap
Aprepitant and fosaprepitant: a 10-year review of efficacy and safety. - Abstract - Europe PMC
Emend (aprepitant) Capsule and Oral Suspension Pediatric Postmarketing Pharmacovigilance Review
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
Aprepitant (Emend): Basics, Side Effects & Reviews
PDF) Best Practice Approach to Successful Conversion of Fosaprepitant to Aprepitant IV in a Large Multisite Community Oncology Infusion Center: A Retrospective Analysis